News

Zogenix to Present at the Jefferies 2017 Global Healthcare Conference

EMERYVILLE, Calif., May 31, 2017 (GLOBE NEWSWIRE) — Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P. Smith, Executive Vice President, Chief Financial Officer & Treasurer and Secretary, will present a corporate overview at the Jefferies 2017 Global Healthcare Conference, taking place on June 6-9, 2017, in New York, NY.

2017-06-20T12:17:33+00:00